1,3-Dicyclohexylurea
1,3-Dicyclohexylurea (DCU) is an orally active and potent sEH (soluble epoxide hydrolase) inhibitor. Oral Delivery of 1,3-Dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive Rats[1].
Product Specifications
CAS Number
[2387-23-7]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Epoxide Hydrolase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/1-3-dicyclohexylurea.html
Purity
99.85
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : ≥ 2.5 mg/mL
Smiles
O=C(NC1CCCCC1)NC2CCCCC2
Molecular Formula
C13H24N2O
Molecular Weight
224.35
Precautions
H302, H315, H319, H335
References & Citations
[1]Ghosh S, et al. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. Basic Clin Pharmacol Toxicol. 2008 May;102 (5) :453-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL511927V 500 µL Each
Gk2 Mouse shRNA Lentiviral Particle (Locus ID 14626)
Sign In for Pricing
View Details 
GTR15383780 1 Vial
Lentiviral human PDAP1 sgRNA gene knockout kit - Lentiviral human PDAP1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 